Sotac Pharmaceuticals Ltd Nine Monthly Results

Gross Sales

77.39

59.4

79.5

Excise Duty

0

0

0

Net Sales

77.39

59.4

79.5

Other Operating Income

0

0

0

Other Income

0.67

0.79

1.57

Total Income

78.05

60.19

81.06

Total Expenditure

70.28

54.57

72.69

PBIDT

7.78

5.63

8.37

Interest

1.89

1.33

2.12

PBDT

5.88

4.29

6.24

Depreciation

2.22

1.67

2.22

Minority Interest Before NP

0

0

0

Tax

1.54

1.2

2.26

Deferred Tax

0.06

0.17

-0.27

Reported Profit After Tax

2.07

1.25

2.03

Minority Interest After NP

0

0

0

Net Profit after Minority Interest

2.64

1.79

2.57

Extra-ordinary Items

-0.13

0.28

1.16

Adjusted Profit After Extra-ordinary item

2.77

1.51

1.41

EPS (Unit Curr.)

2.41

2.22

11.19

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

11.05

8.05

2.3

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

10.05

9.47

10.52

PBDTM(%)

7.59

7.22

7.84

PATM(%)

2.67

2.1

2.55